Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
8.05
-0.01 (-0.12%)
At close: Aug 28, 2025, 4:00 PM
8.05
0.00 (0.00%)
After-hours: Aug 28, 2025, 4:10 PM EDT

Nasus Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Selling, General & Admin
0.740.580.93
Research & Development
0.340.571.12
Operating Expenses
1.081.152.04
Operating Income
-1.08-1.15-2.04
Interest Expense
-0.03-0.05-0.02
Other Non Operating Income (Expenses)
-0-0.03-0
EBT Excluding Unusual Items
-1.11-1.22-2.06
Gain (Loss) on Sale of Investments
-0.440.22-0.09
Pretax Income
-1.55-1.01-2.15
Earnings From Continuing Operations
-1.55-1.01-2.15
Earnings From Discontinued Operations
0.02-0.050.44
Net Income
-1.53-1.05-1.71
Net Income to Common
-1.53-1.05-1.71
Shares Outstanding (Basic)
777
Shares Outstanding (Diluted)
777
Shares Change (YoY)
-0.43%2.44%-
EPS (Basic)
-0.22-0.15-0.25
EPS (Diluted)
-0.22-0.20-0.25
EBIT
-1.08-1.15-2.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q